Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial    source : Www.oramed.com    save search
Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19 Vaccine Trial in South Africa
Published: 2021-12-14 (Crawled : 13:30) - oramed.com
ORMP A | $2.265 2.96% 2.87% 110K twitter stocktwits trandingview |
Health Technology
 | | O: -3.6% H: 1.87% C: -2.4%
covid-19 trial covid phase 1 vaccine enroll phase 2 africa
Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial
Published: 2021-07-21 (Crawled : 13:00) - oramed.com
ORMP A | $2.265 2.96% 2.87% 110K twitter stocktwits trandingview |
Health Technology
 | | O: 1.39% H: 9.85% C: 8.15%
vaccine trial approval
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.